| |
| |
|
| Insider
Information: |
Papapetropoulos Spyridon |
| Relationship: |
Director |
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
25,739 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,196 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,739 |
|
|
| Total
Value |
$6,196 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adamas Pharmaceuticals Inc |
ADMS |
Director |
2021-11-24 |
0 |
2020-11-22 |
0 |
Premium* |
|
|
Vigil Neuroscience, Inc. |
VIGL |
Chief Medical Officer |
2022-11-18 |
4,000 |
2022-05-03 |
0 |
Premium* |
|
|
Lipocine Inc |
LPCN |
Director |
2022-11-22 |
21,739 |
2022-11-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LPCN |
Lipocine Inc |
Director |
– • – |
2022-11-22 |
4 |
B |
$0.47 |
$10,217 |
D/D |
21,739 |
21,739 |
2.39 |
% |
|
| VIGL |
Vigil Neuroscience, Inc. |
Chief Medical Officer |
• – – |
2022-11-18 |
4 |
OE |
$1.89 |
$567 |
D/D |
300 |
4,300 |
0 |
- |
|
| VIGL |
Vigil Neuroscience, Inc. |
Chief Medical Officer |
• – – |
2022-11-18 |
4 |
AS |
$14.00 |
$4,200 |
D/D |
(300) |
4,000 |
0 |
- |
|
| VIGL |
Vigil Neuroscience, Inc. |
Chief Medical Officer |
• – – |
2022-05-03 |
4 |
B |
$3.40 |
$13,591 |
D/D |
4,000 |
4,000 |
2.74 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-11-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,975) |
0 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
20,975 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-03-11 |
4 |
B |
$5.06 |
$30,234 |
D/D |
5,975 |
15,975 |
2.39 |
% |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2020-11-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
